Apr 12 |
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
|
Apr 11 |
Aquestive Therapeutics a new overweight at Piper on oral film products
|
Apr 11 |
Piper starts Aquestive at overweight, cites allergy reaction treatment
|
Apr 9 |
Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024
|
Apr 3 |
Aquestive Therapeutics files for $250M mixed securities shelf
|
Apr 2 |
Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note
|
Apr 1 |
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
|
Mar 25 |
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
|
Mar 22 |
Aquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know
|
Mar 20 |
Dow Surges 350 Points; Fed Holds Rates Steady
|